GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Opthea Ltd (NAS:OPT) » Definitions » Institutional Ownership

OPT (Opthea) Institutional Ownership : 3.51% (As of Apr. 22, 2025)


View and export this data going back to 2011. Start your Free Trial

What is Opthea Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Opthea's institutional ownership is 3.51%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Opthea's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Opthea's Float Percentage Of Total Shares Outstanding is 74.12%.

Opthea Institutional Ownership Historical Data

The historical data trend for Opthea's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Opthea Institutional Ownership Chart

Opthea Historical Data

The historical data trend for Opthea can be seen below:

2024-06-30 2024-07-31 2024-08-31 2024-09-30 2024-10-31 2024-11-30 2024-12-31 2025-01-31 2025-02-28 2025-03-31
Institutional Ownership 0.79 0.79 0.70 0.03 0.03 0.18 0.18 0.18 0.18 0.18

Opthea Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

Opthea Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Opthea Ltd (NAS:OPT) » Definitions » Institutional Ownership
Comparable Companies
ASX:CU6 ASX:PYC ASX:BOT ASX:CUV ASX:IMM ASX:OCC ASX:IMU ASX:DXB ASX:RAC ASX:PAR VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
UKJ:Germany OPT:Australia
Address
650 Chapel Street, Level 4, Suite 0403, South Yarra, VIC, AUS, 3141
Website
https://www.opthea.com
Opthea Ltd operates in one industry being the medical technology and healthcare. It is focused on developing biological therapeutics for eye diseases. The company is developing a novel biologic therapy, OPT-302, for the treatment of eye diseases. Its products are based on the intellectual property portfolio covering Vascular Endothelial Growth Factors C and D and R3 targets. Opthea's development activities are based on an intellectual property portfolio covering key targets Vascular Endothelial Growth Factors VEGF-C, VEGF-D and VEGF Receptor-3 for the treatment of diseases associated with blood and lymphatic vessel growth, as well as vascular leakage. The company geographically operates Australia and United States.